Zobrazeno 1 - 10
of 506
pro vyhledávání: '"Richard F Schlenk"'
Autor:
Frank G Rücker, Lars Bullinger, Sibylle Cocciardi, Sabrina Skambraks, Tamara J Luck, Daniela Weber, Isabelle Schneider, Andrea Corbacioglu, Verena I Gaidzik, Ekaterina Jahn, Nikolaus Jahn, Silke Kapp-Schwoerer, Anika Schrade, Frauke Theis, Walter Fiedler, Helmut R Salih, Gerald Wulf, Hans Salwender, Thomas Schroeder, Katharina S Götze, Thomas Kindler, Michael Lübbert, Richard F Schlenk, Felicitas Thol, Michael Heuser, Arnold Ganser, Hartmut Döhner, Konstanze Döhner
Publikováno v:
HemaSphere, Vol 7, p e29390a8 (2023)
Externí odkaz:
https://doaj.org/article/eae6758e5a2d4ab493e1f62d7fc2e7eb
Autor:
Gundram Jung, Jonas S Heitmann, Juliane S Walz, Martin Pflügler, Joseph Kauer, Richard F Schlenk, Helmut R Salih
Publikováno v:
BMJ Open, Vol 10, Iss 10 (2020)
Introduction Prostate cancer is the second most common cancer in men worldwide. When the disease becomes resistant to androgen-deprivation therapy, treatment options are sparse. To address the high medical need in castration-resistant prostate cancer
Externí odkaz:
https://doaj.org/article/db1de9e8f984491ea31351891b96898a
Autor:
Stefanie Hieke, Axel Benner, Richard F Schlenk, Martin Schumacher, Lars Bullinger, Harald Binder
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0155226 (2016)
Clinical cohorts with time-to-event endpoints are increasingly characterized by measurements of a number of single nucleotide polymorphisms that is by a magnitude larger than the number of measurements typically considered at the gene level. At the s
Externí odkaz:
https://doaj.org/article/888780320d2a42caa8b2af5373c205c2
Autor:
Florian Ramdohr, Alice Fabarius, Bettina Maier, Daniela Bretschneider, Anna Jauch, Astrid Monecke, Klaus H. Metzeler, Johannes W. G. Janssen, Richard F. Schlenk, Sabine Kayser
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The presence of the translocation t(9;22)(q34;q11), leading to the BCR::ABL1 fusion transcript, is the hallmark of chronic myeloid leukemia (CML). Nevertheless, atypical presentation at diagnosis can be challenging. However, although most patients wi
Externí odkaz:
https://doaj.org/article/63186edfcbc94beea493ea00d3268656
Autor:
Alexander Waclawiczek, Aino-Maija Leppä, Simon Renders, Karolin Stumpf, Cecilia Reyneri, Barbara Betz, Maike Janssen, Rabia Shahswar, Elisa Donato, Darja Karpova, Vera Thiel, Julia M. Unglaub, Susanna Grabowski, Stefanie Gryzik, Lisa Vierbaum, Richard F. Schlenk, Christoph Röllig, Michael Hundemer, Caroline Pabst, Michael Heuser, Simon Raffel, Carsten Müller-Tidow, Tim Sauer, Andreas Trumpp
Publikováno v:
Cancer Discovery. :OF1-OF20
The BCL2 inhibitor venetoclax (VEN) in combination with azacitidine (5-AZA) is currently transforming acute myeloid leukemia (AML) therapy. However, there is a lack of clinically relevant biomarkers that predict response to 5-AZA/VEN. Here, we integr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51a7713e30e7d8c3b809c403451fd1f5
https://doi.org/10.1158/2159-8290.cd-22-0939
https://doi.org/10.1158/2159-8290.cd-22-0939
Autor:
Harry P Erba, Pau Montesinos, Hee-Je Kim, Elżbieta Patkowska, Radovan Vrhovac, Pavel Žák, Po-Nan Wang, Tsvetomir Mitov, James Hanyok, Yasser Mostafa Kamel, Jaime E Connolly Rohrbach, Li Liu, Aziz Benzohra, Arnaud Lesegretain, Jorge Cortes, Alexander E Perl, Mikkael A Sekeres, Hervé Dombret, Sergio Amadori, Jianxiang Wang, Mark J Levis, Richard F Schlenk
Publikováno v:
The Lancet. 401:1571-1583
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bd4edc00956dbe8a70604670af6a6c7
https://doi.org/10.1016/s0140-6736(23)00464-6
https://doi.org/10.1016/s0140-6736(23)00464-6
Autor:
Sonia Jaramillo, Richard F. Schlenk
Publikováno v:
Haematologica. 108:342-352
For several decades, the treatment for acute myeloid leukemia (AML) has been a dichotomous choice between intensive chemotherapy strategies with curative intent and non-intensive options including supportive care. Patients’ age and fitness, as well
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::320a5f282a63573c19b94dc0ddb9697d
https://doi.org/10.3324/haematol.2022.280802
https://doi.org/10.3324/haematol.2022.280802
Autor:
Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Michael W M Kühn, Thomas Schroeder, Karin Mayer, Michael Lübbert, Mohammed Wattad, Katharina Götze, Lars Fransecky, Elisabeth Koller, Gerald Wulf, Jan Schleicher, Mark Ringhoffer, Richard Greil, Bernd Hertenstein, Jürgen Krauter, Uwe M Martens, David Nachbaur, Maisun Abu Samra, Sigrid Machherndl-Spandl, Nadezda Basara, Claudia Leis, Anika Schrade, Silke Kapp-Schwoerer, Sibylle Cocciardi, Lars Bullinger, Felicitas Thol, Michael Heuser, Peter Paschka, Verena I Gaidzik, Maral Saadati, Axel Benner, Richard F Schlenk, Konstanze Döhner, Arnold Ganser, Michael W.M. Kühn, Mohammad Wattad, Uwe M. Martens, Verena I. Gaidzik, Richard F. Schlenk
Publikováno v:
The Lancet Haematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2245fcb24dabffd6229acf25195a4709
https://doi.org/10.1016/s2352-3026(23)00089-3
https://doi.org/10.1016/s2352-3026(23)00089-3
Autor:
Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Michael W.M. Kühn, Thomas Schroeder, Karin Mayer, Michael Lübbert, Mohammad Wattad, Katharina Götze, Lars Fransecky, Elisabeth Koller, Gerald Wulf, Jan Schleicher, Mark Ringhoffer, Richard Greil, Bernd Hertenstein, Jürgen Krauter, Uwe M. Martens, David Nachbaur, Maisun Abu Samra, Sigrid Machherndl-Spandl, Nadezda Basara, Claudia Leis, Anika Schrade, Silke Kapp-Schwoerer, Lars Bullinger, Felicitas R. Thol, Michael Heuser, Peter Paschka, Verena I. Gaidzik, Maral Saadati, Axel Benner, Richard F. Schlenk, Konstanze Döhner, Arnold Ganser
Publikováno v:
Blood. 140:2010-2013
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd095e89d69c00c5a44aaf26b2714a5f
https://doi.org/10.1182/blood-2022-166084
https://doi.org/10.1182/blood-2022-166084
Autor:
Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Gerald Wulf, Helmut Salih, Michael Lübbert, Michael W. M. Kühn, Thomas Schroeder, Hans Salwender, Katharina Götze, Jörg Westermann, Lars Fransecky, Karin Mayer, Bernd Hertenstein, Mark Ringhoffer, Hans-Joachim Tischler, Sigrid Machherndl-Spandl, Anika Schrade, Peter Paschka, Verena I. Gaidzik, Frauke Theis, Felicitas Thol, Michael Heuser, Richard F. Schlenk, Lars Bullinger, Maral Saadati, Axel Benner, Richard Larson, Richard Stone, Konstanze Döhner, Arnold Ganser
Publikováno v:
Blood Advances. 6:5345-5355
We conducted a single-arm, phase 2 trial (German-Austrian Acute Myeloid Leukemia Study Group [AMLSG] 16-10) to evaluate midostaurin with intensive chemotherapy followed by allogeneic hematopoietic-cell transplantation (HCT) and a 1-year midosta urin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a223a5f19d7ec75ecae762a9a552cd5b
https://doi.org/10.1182/bloodadvances.2022007223
https://doi.org/10.1182/bloodadvances.2022007223